We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
AltaGas Ltd (PK) | USOTC:AGEEF | OTCMarkets | Preference Share |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.69 | 0.0033 | 31.00 | 0.00 | 01:00:00 |
Delaware | 001-34827 | 27-2301797 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
5619 Denver Tech Center Parkway, Suite 1000, Greenwood Village, CO | 80111 | |
(Address of principal executive offices) | (Zip Code) |
Exhibit Number | Description | ||
99.1 | Press Release issued by Molycorp, Inc. on March 16, 2015 |
MOLYCORP, INC. | ||
By: | /s/ Michael F. Doolan | |
Name: | Michael F. Doolan | |
Title: | Chief Financial Officer | |
Date: March 16, 2015 |
Exhibit Number | Description | ||
99.1 | Press Release issued by Molycorp, Inc. on March 16, 2015 |
• | The Company reported higher production volumes in the fourth quarter of 2014 at its Mountain Pass, California rare earth facility, with 1,328 metric tons ("mt") of rare earth oxide ("REO") equivalent production. That compares to 1,034 mt in the fourth quarter of 2013 and 691 mt in the third quarter of 2014. Full year 2014 production at Mountain Pass totaled approximately 4,769 mt, compared to 3,473 mt in 2013. |
• | The Chlor-Alkali plant at Mountain Pass is performing well and the Company is able to produce or purchase sufficient supplies of hydrochloric acid for rare earth production. |
• | Per-unit cash production costs at Mountain Pass declined in the fourth quarter of 2014 to $21.02 per kilogram, a 38% decrease over the third quarter of 2014 costs of $33.80 per kilogram. |
• | The Company reported fourth quarter product sales volume of 3,149 mt, a 6% decrease over the third quarter, at an average selling price ("ASP") of $36.91 per kilogram. For the full year 2014, the Company reported sales volume of 13,019 mt, a 1% increase over 2013, at an ASP of approximately $36.53 per kilogram. |
• | Net revenues for the quarter were $116.2 million, a 6% decrease from the third quarter. Full year 2014 net revenues were $475.6 million, a 14% decrease as compared to 2013. |
• | The Company reported a net loss of $1.43 per share for the quarter. The Company reported a net loss of $0.39 per share for the quarter on an adjusted non-GAAP basis. |
• | For the full year 2014, the Company reported a net loss of $2.70 per share. On an adjusted non-GAAP basis, the Company reported a net loss of $1.31 per share for the full year, due largely to impairment of goodwill and other intangible assets and write-offs of certain tangible assets. |
At December 31, | |||||||
2014 | 2013 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 211,685 | $ | 314,317 | |||
Trade accounts receivable, net | 44,575 | 61,757 | |||||
Inventory | 169,323 | 171,783 | |||||
Prepaid expenses and other current assets | 29,332 | 29,210 | |||||
Total current assets | 454,915 | 577,067 | |||||
Non-current assets: | |||||||
Deposits | 31,078 | 25,997 | |||||
Property, plant and equipment, net | 1,707,970 | 1,762,874 | |||||
Inventory | 25,127 | 25,329 | |||||
Intangible assets, net | 215,871 | 330,867 | |||||
Investments | 8,801 | 48,875 | |||||
Goodwill | 102,808 | 228,750 | |||||
Other non-current assets | 29,416 | 7,043 | |||||
Total non-current assets | 2,121,071 | 2,429,735 | |||||
Total assets | $ | 2,575,986 | $ | 3,006,802 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Trade accounts payable | $ | 40,842 | $ | 84,449 | |||
Accrued expenses | 51,966 | 48,501 | |||||
Debt and capital lease obligations | 12,560 | 16,362 | |||||
Other current liabilities | 4,686 | 4,063 | |||||
Total current liabilities | 110,054 | 153,375 | |||||
Non-current liabilities: | |||||||
Asset retirement obligation | 17,799 | 16,966 | |||||
Deferred tax liabilities | 63,802 | 85,481 | |||||
Debt and capital lease obligations | 1,559,781 | 1,363,916 | |||||
Other non-current liabilities | 20,247 | 10,002 | |||||
Total non-current liabilities | 1,661,629 | 1,476,365 | |||||
Total liabilities | $ | 1,771,683 | $ | 1,629,740 | |||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock, $0.001 par value; 700,000,000 shares authorized at December 31, 2014 and 350,000,000 at December 31, 2013 | 260 | 241 | |||||
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2013 | — | 2 | |||||
Additional paid-in capital | 2,245,478 | 2,194,405 | |||||
Accumulated other comprehensive loss | (3,323 | ) | (6,451 | ) | |||
Accumulated deficit | (1,445,408 | ) | (840,474 | ) | |||
Total Molycorp stockholders’ equity | 797,007 | 1,347,723 | |||||
Noncontrolling interests | 7,296 | 29,339 | |||||
Total stockholders’ equity | 804,303 | 1,377,062 | |||||
Total liabilities and stockholders’ equity | $ | 2,575,986 | $ | 3,006,802 |
Quarter Ended | Years Ended December 31, | ||||||||||
December 31, 2014 | 2014 | 2013 | |||||||||
Revenues | $ | 116,242 | $ | 475,612 | $ | 554,390 | |||||
Costs of sales: | |||||||||||
Costs excluding depreciation and amortization | (122,912 | ) | (481,417 | ) | (553,831 | ) | |||||
Depreciation and amortization | (38,174 | ) | (93,782 | ) | (67,727 | ) | |||||
Gross loss | (44,844 | ) | (99,587 | ) | (67,168 | ) | |||||
Operating expenses: | |||||||||||
Selling, general and administrative | (14,204 | ) | (74,490 | ) | (107,169 | ) | |||||
Corporate development | — | — | (247 | ) | |||||||
Depreciation, amortization and accretion | (7,327 | ) | (29,879 | ) | (38,037 | ) | |||||
Research and development | (3,662 | ) | (15,265 | ) | (23,172 | ) | |||||
Impairment of goodwill and other long-lived assets | (231,650 | ) | (231,650 | ) | (120,898 | ) | |||||
Operating loss | (301,687 | ) | (450,871 | ) | (356,691 | ) | |||||
Other (expense) income: | |||||||||||
Other (expense) income | (3,615 | ) | (5,092 | ) | 1,886 | ||||||
Foreign exchange loss, net | (2,784 | ) | (3,146 | ) | (376 | ) | |||||
Interest expense, net of capitalized interest | (55,008 | ) | (167,375 | ) | (67,684 | ) | |||||
Gain on extinguishment of convertible notes, net | 19,719 | 19,719 | — | ||||||||
Impairment of investments at cost | — | (12,000 | ) | (9,411 | ) | ||||||
(41,688 | ) | (167,894 | ) | (75,585 | ) | ||||||
Loss from continuing operations before income taxes and equity earnings | (343,375 | ) | (618,765 | ) | (432,276 | ) | |||||
Income tax benefit | 16,832 | 22,594 | 70,943 | ||||||||
Equity in loss of affiliates | (21,395 | ) | (26,763 | ) | (9,169 | ) | |||||
Loss from continuing operations | (347,938 | ) | (622,934 | ) | (370,502 | ) | |||||
Loss from discontinued operations, net of tax | — | — | (6,427 | ) | |||||||
Net loss | (347,938 | ) | (622,934 | ) | (376,929 | ) | |||||
Net loss attributable to noncontrolling interests | 18,142 | 18,000 | 2,546 | ||||||||
Net loss attributable to Molycorp stockholders | $ | (329,796 | ) | $ | (604,934 | ) | $ | (374,383 | ) | ||
Net loss | $ | (347,938 | ) | $ | (622,934 | ) | $ | (376,929 | ) | ||
Other comprehensive loss, net of tax: | |||||||||||
Foreign currency translation adjustments | 13,524 | 4,271 | 1,623 | ||||||||
Actuarial (loss) gain | (1,143 | ) | (1,143 | ) | 1,359 | ||||||
Comprehensive loss | $ | (335,557 | ) | $ | (619,806 | ) | $ | (373,947 | ) | ||
Comprehensive (loss) income attributable to: | |||||||||||
Molycorp stockholders | (317,415 | ) | (601,806 | ) | (371,401 | ) | |||||
Noncontrolling interests | (18,142 | ) | (18,000 | ) | (2,546 | ) | |||||
$ | (335,557 | ) | $ | (619,806 | ) | $ | (373,947 | ) | |||
Loss per share of common stock: | |||||||||||
Basic: | |||||||||||
Continuing operations | $ | (1.43 | ) | $ | (2.70 | ) | $ | (2.17 | ) | ||
Discontinued operations | — | — | (0.04 | ) | |||||||
$ | (1.43 | ) | $ | (2.70 | ) | $ | (2.21 | ) |
Years Ended December 31, | |||||||
2014 | 2013 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (622,934 | ) | $ | (376,929 | ) | |
Adjustments to reconcile net loss to net cash from operating activities: | |||||||
Depreciation, amortization and accretion | 123,661 | 105,764 | |||||
Deferred income tax benefit | (38,996 | ) | (68,290 | ) | |||
Inventory write-downs | 84,414 | 100,346 | |||||
Release of inventory step-up value | 993 | 3,068 | |||||
Impairment of goodwill and other long-lived assets | 231,650 | 120,898 | |||||
Impairment of investments | 12,000 | 9,411 | |||||
Stock-based compensation | 5,261 | 5,392 | |||||
Equity in results of affiliates | 26,763 | 9,169 | |||||
Gain on extinguishment of convertible notes, net | (19,719 | ) | — | ||||
PIK interest | 3,851 | — | |||||
Change in fair value of embedded derivative | 3,879 | — | |||||
Amortization of issuance costs | 7,444 | — | |||||
Impairment of other receivables | 3,292 | — | |||||
Other operating activities | 5,021 | 1,539 | |||||
Net change in operating assets and liabilities | (48,784 | ) | (64,719 | ) | |||
Net cash used in operating activities | (222,204 | ) | (154,351 | ) | |||
Cash flows from investing activities: | |||||||
Investment in joint ventures | (703 | ) | (3,423 | ) | |||
Dividends received from equity investment | 2,014 | — | |||||
Capital expenditures | (86,158 | ) | (379,312 | ) | |||
Recovery from insurance claims | 12,900 | — | |||||
Other investing activities | 984 | 5,477 | |||||
Net cash used in investing activities | (70,963 | ) | (377,258 | ) | |||
Cash flows from financing activities: | |||||||
Repayments of debt | (7,825 | ) | (26,823 | ) | |||
Net proceeds from sale of common stock | — | 495,717 | |||||
Issuance of 5.50% Convertible Notes | — | 165,600 | |||||
Payments of preferred dividends | (2,846 | ) | (11,385 | ) | |||
Dividends paid to noncontrolling interests | (4,222 | ) | (4,546 | ) | |||
Debt issuance costs | (15,260 | ) | — | ||||
Proceeds from the 2014 Financings | 250,000 | — | |||||
Partial repayment of convertible notes | (27,495 | ) | — | ||||
Other financing activities | — | (1,297 | ) | ||||
Net cash provided by financing activities | 192,352 | 617,266 | |||||
Effect of exchange rate changes on cash | (1,817 | ) | 870 | ||||
Net change in cash and cash equivalents | (102,632 | ) | 86,527 | ||||
Cash and cash equivalents at beginning of the year | 314,317 | 227,790 | |||||
Cash and cash equivalents at end of year | $ | 211,685 | $ | 314,317 |
Year ended December 31, 2014 | Resources | Chemicals and Oxides | Magnetic Materials and Alloys | Rare Metals | Corporate and other(a) | Eliminations(b) | Total Molycorp, Inc. | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||
External | $ | 14,097 | $ | 159,365 | $ | 222,795 | $ | 79,355 | $ | — | $ | 475,612 | |||||||||||||||
Inter-segment | 34,093 | 22,056 | 7,591 | — | (63,740 | ) | — | ||||||||||||||||||||
Total revenues | $ | 48,190 | $ | 181,421 | $ | 230,386 | $ | 79,355 | $ | (63,740 | ) | $ | 475,612 | ||||||||||||||
OIBDA | (146,157 | ) | (202,588 | ) | 52,966 | (442 | ) | ||||||||||||||||||||
Depreciation, amortization and accretion | (78,739 | ) | (17,401 | ) | (16,956 | ) | (10,343 | ) | |||||||||||||||||||
Operating (loss) income (c) | $ | (224,896 | ) | $ | (219,989 | ) | $ | 36,010 | $ | (10,785 | ) | $ | (33,195 | ) | $ | 1,984 | $ | (450,871 | ) | ||||||||
Other expense | (5,092 | ) | |||||||||||||||||||||||||
Foreign exchange loss, net | (3,146 | ) | |||||||||||||||||||||||||
Interest expense, net of capitalized interest | (167,375 | ) | |||||||||||||||||||||||||
Gain on extinguishment of convertible notes, net | 19,719 | ||||||||||||||||||||||||||
Impairment of investments | $ | (12,000 | ) | ||||||||||||||||||||||||
Loss before income taxes and equity earnings | $ | (618,765 | ) |
Quarter ended December 31, 2014 | Resources | Chemicals and Oxides | Magnetic Materials and Alloys | Rare Metals | Corporate and other(a) | Eliminations(b) | Total Molycorp, Inc. | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||
External | $ | 4,145 | $ | 36,844 | $ | 53,535 | $ | 21,718 | $ | — | $ | 116,242 | |||||||||||||||
Inter-segment | 4,510 | 5,918 | 3,865 | — | (14,293 | ) | — | ||||||||||||||||||||
Total revenues | $ | 8,655 | $ | 42,762 | $ | 57,400 | $ | 21,718 | $ | (14,293 | ) | $ | 116,242 | ||||||||||||||
OIBDA | (48,327 | ) | (214,975 | ) | 13,762 | (1,706 | ) | ||||||||||||||||||||
Depreciation, amortization and accretion | (31,307 | ) | (5,797 | ) | (4,226 | ) | (4,116 | ) | |||||||||||||||||||
Operating (loss) income (c) | $ | (79,634 | ) | $ | (220,772 | ) | $ | 9,536 | $ | (5,822 | ) | $ | (7,936 | ) | $ | 2,941 | $ | (301,687 | ) | ||||||||
Other expense | (3,615 | ) | |||||||||||||||||||||||||
Foreign exchange loss, net | (2,784 | ) | |||||||||||||||||||||||||
Interest expense, net of capitalized interest | (55,008 | ) | |||||||||||||||||||||||||
Gain on extinguishment of convertible notes, net | 19,719 | ||||||||||||||||||||||||||
Loss before income taxes and equity earnings | $ | (343,375 | ) |
(a) | Includes business development costs, personnel costs, stock-based compensation, accounting and legal fees, occupancy expense, information technology costs and interest expense. |
(b) | Consist of inter-segment sales and gross profits eliminations as well as eliminations of lower of cost or market adjustments related to inter-segment inventory. |
(c) | Includes impairment of goodwill and other long-lived assets in some segments. |
Year ended December 31, 2013 | Resources | Chemicals and Oxides | Magnetic Materials and Alloys | Rare Metals | Corporate and other (a) | Eliminations(b) | Total Molycorp, Inc. | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||
External | $ | 33,621 | $ | 181,815 | $ | 252,713 | $ | 86,241 | $ | — | $ | 554,390 | |||||||||||||||
Inter-segment | 26,040 | 37,256 | — | — | (63,296 | ) | — | ||||||||||||||||||||
Total revenues | $ | 59,661 | $ | 219,071 | $ | 252,713 | $ | 86,241 | $ | (63,296 | ) | $ | 554,390 | ||||||||||||||
OIBDA | (177,384 | ) | (65,135 | ) | 50,899 | (12,456 | ) | ||||||||||||||||||||
Depreciation, amortization and accretion | (46,318 | ) | (22,754 | ) | (27,812 | ) | (8,652 | ) | |||||||||||||||||||
Operating (loss) income (c) | $ | (223,702 | ) | $ | (87,889 | ) | $ | 23,087 | $ | (21,108 | ) | $ | (46,126 | ) | $ | (953 | ) | $ | (356,691 | ) | |||||||
Other expense | 1,886 | ||||||||||||||||||||||||||
Foreign exchange loss, net | (376 | ) | |||||||||||||||||||||||||
Interest expense, net of capitalized interest | (67,684 | ) | |||||||||||||||||||||||||
Impairment of investment at cost | (9,411 | ) | |||||||||||||||||||||||||
Loss before income taxes and equity earnings | $ | (432,276 | ) |
Quarter Ended | Years Ended December 31, | ||||||||||
December 31, 2014 | 2014 | 2013 | |||||||||
(In thousands, except share and per share amounts) | |||||||||||
Net loss attributable to Molycorp stockholders | $ | (329,795 | ) | $ | (604,934 | ) | $ | (374,383 | ) | ||
Dividends on Convertible Preferred Stock | — | (2,846 | ) | (11,385 | ) | ||||||
Loss attributable to common stockholders | (329,795 | ) | (607,780 | ) | (385,768 | ) | |||||
Continuing operations | $ | (329,795 | ) | $ | (607,780 | ) | $ | (379,341 | ) | ||
Discontinued operations | — | — | (6,427 | ) | |||||||
$ | (329,795 | ) | $ | (607,780 | ) | $ | (385,768 | ) | |||
Weighted average common shares outstanding—basic | 229,960,050 | 224,978,752 | 174,528,717 | ||||||||
Basic loss per share from: | |||||||||||
Continuing operations | $ | (1.43 | ) | $ | (2.70 | ) | $ | (2.17 | ) | ||
Discontinued operations | — | — | (0.04 | ) | |||||||
$ | (1.43 | ) | $ | (2.70 | ) | $ | (2.21 | ) |
Quarter Ended | Years Ended December 31, | ||||||||||
December 31, 2014 | 2014 | 2013 | |||||||||
Revenues (in thousands) | |||||||||||
Resources (1) | $ | 8,655 | $ | 48,190 | $ | 59,661 | |||||
Chemicals and Oxides (2) | 42,762 | 181,421 | 219,071 | ||||||||
Magnetic Materials and Alloys (3) | 57,400 | 230,386 | 252,713 | ||||||||
Rare Metals (4) | 21,718 | 79,355 | 86,241 | ||||||||
Inter-segment eliminations | (14,293 | ) | (63,740 | ) | (63,296 | ) | |||||
Total Net Revenues | $ | 116,242 | $ | 475,612 | $ | 554,390 | |||||
Sales volume (in metric tons) | |||||||||||
Resources | 898 | 3,945 | 3,926 | ||||||||
Chemicals and Oxides (b) | 1,446 | 6,605 | 6,346 | ||||||||
Magnetic Materials and Alloys (a) | 1,440 | 5,748 | 5,884 | ||||||||
Rare Metals | 126 | 410 | 333 | ||||||||
Inter-segment eliminations | (761 | ) | (3,689 | ) | (3,597 | ) | |||||
(a) Includes magnetic powders and rare earth alloys. | |||||||||||
(b) Sales volume and ASP for 2013 have been restated to exclude 242 mt of certain non-rare earth by-products that this segment sold for a nominal amount. | |||||||||||
ASP per kilogram | |||||||||||
Resources | $ | 9.64 | $ | 12.21 | $ | 15.20 | |||||
Chemicals and Oxides (b) | 29.57 | 27.42 | 34.49 | ||||||||
Magnetic Materials and Alloys | 39.86 | 40.08 | 42.95 | ||||||||
Rare Metals | 172.38 | 193.41 | 264.13 | ||||||||
1. The Resources segment includes operations at our Mountain Pass facility where we conduct rare earth minerals extraction and processing to produce: purified unseparated light rare earth concentrates, or LREC; separated rare earth oxides, including lanthanum, cerium and neodymium/praseodymium; heavy rare earth concentrates, which include samarium, europium, gadolinium, terbium, dysprosium and others; and a line of proprietary rare earth-based water treatment products, including SorbX® and PhosFIX™. | |||||||||||
2. The Chemicals and Oxides segment includes: production of rare earths at our operations at Molycorp Silmet; separated heavy rare earth oxides and other custom engineered materials from our facilities in Jiangyin, Jiangsu Province, China; and production of rare earths, salts of REEs, zirconium-based engineered materials and mixed rare earth/zirconium oxides from our facilities in Zibo, Shandong Province, China. Rare earths and zirconium applications from products made in this segment include catalytic converters, computers, television display panels, optical lenses, mobile phones, electronic chips, and many others. | |||||||||||
3. The Magnetic Materials and Alloys segment includes the production of Neo Powders™ through our wholly-owned manufacturing facilities in Tianjin, China, and Korat, Thailand, under the Molycorp Magnequench brand. This operating segment also includes manufacturing of neodymium and samarium magnet alloys, other specialty alloy products and rare earth metals at our MMA facility in Tolleson, Arizona. Neo Powders™ are used in the production of high performance, bonded NdFeB permanent magnets, which are found in micro-motors, precision motors, sensors, and other applications requiring high levels of magnetic strength, flexibility, small size, reduced weight, and energy efficient performance. | |||||||||||
4. The Rare Metals segment produces, reclaims, refines and markets high value niche metals and their compounds that include gallium, indium, rhenium, tantalum, and niobium. Operations in this segment are distributed in several locations: Quapaw, Oklahoma; Blanding, Utah; Peterborough, Ontario, Canada; Sagard, Germany; Hyeongok Industrial Zone in South Korea; and Sillamäe, Estonia. Applications from products made in this segment include wireless technologies, LEDs, flat panel displays, turbines, solar power catalysts, steel additives, electronics applications, and many others. |
Adjusted Net Loss | |||||||
December 31, 2014 | |||||||
Quarter Ended | Year Ended | ||||||
(In thousands, except share and per share amounts) | |||||||
Net loss attributable to Molycorp stockholders | $ | (329,795 | ) | $ | (604,934 | ) | |
Certain non-cash and other items: | |||||||
Stock-based compensation | 1,476 | 5,261 | |||||
Inventory write-downs (Mountain Pass) | 26,803 | 72,485 | |||||
Impact of purchase accounting on cost of inventory sold | 252 | 993 | |||||
Impairment of goodwill and other long-lived assets | 231,356 | 231,650 | |||||
Write-down of investments and related receivables | 22,986 | 34,986 | |||||
Gain on debt conversion | (21,683 | ) | (21,683 | ) | |||
Out-of-ordinary items: | |||||||
Water removal | 551 | 10,737 | |||||
Income tax effect of above adjustments | (20,972 | ) | (21,201 | ) | |||
Adjusted net loss | (89,026 | ) | (291,706 | ) | |||
Dividends on Convertible Preferred Stock | — | (2,846 | ) | ||||
Adjusted net loss attributed to common stockholders | $ | (89,026 | ) | $ | (294,552 | ) | |
Weighted average common shares outstanding | 229,960,050 | 224,978,752 | |||||
Adjusted net loss per share | $ | (0.39 | ) | $ | (1.31 | ) |
OIBDA and Adjusted OIBDA | |||||||
December 31, 2014 | |||||||
Consolidated | Quarter Ended | Year Ended | |||||
(In thousands) | |||||||
Operating loss | $ | (301,687 | ) | $ | (450,871 | ) | |
Depreciation and amortization included in costs of sales | 38,174 | 93,782 | |||||
Depreciation, amortization and accretion | 7,327 | 29,879 | |||||
OIBDA | (256,186 | ) | (327,210 | ) | |||
Adjusted OIBDA by Segment | |||||||
Resources | |||||||
OIBDA | $ | (48,327 | ) | $ | (146,157 | ) | |
Stock-based compensation | 180 | 827 | |||||
Inventory write-downs | 26,803 | 72,485 | |||||
Impairment of long-lived assets | 13,567 | 13,567 | |||||
Water removal | 551 | 10,737 | |||||
Adjusted OIBDA - Resources | $ | (7,226 | ) | $ | (48,541 | ) | |
Chemicals and Oxides | |||||||
OIBDA | $ | (214,975 | ) | $ | (202,588 | ) | |
Stock-based compensation | 223 | 834 | |||||
Impact of purchase accounting on cost of inventory sold | 252 | 441 | |||||
Impairment of goodwill and other long-lived assets | 215,567 | 215,567 | |||||
Adjusted OIBDA - Chemicals and Oxides | $ | 1,067 | $ | 14,254 | |||
Magnetic Materials and Alloys | |||||||
OIBDA | $ | 13,762 | $ | 52,966 | |||
Stock-based compensation | 168 | 669 | |||||
Impact of purchase accounting on cost of inventory sold | — | (45 | ) | ||||
Impairment of long-lived assets | 144 | 174 | |||||
Adjusted OIBDA - Magnetic Materials and Alloys | $ | 14,074 | $ | 53,764 | |||
Rare Metals | |||||||
OIBDA | $ | (1,706 | ) | $ | (442 | ) | |
Stock-based compensation | 28 | 108 | |||||
Impact of purchase accounting on cost of inventory sold | — | 598 | |||||
Impairment of goodwill and other long-lived assets | 2,077 | 2,077 | |||||
Adjusted OIBDA - Rare Metals | 399 | 2,341 | |||||
Corporate and other | (7,004 | ) | (29,886 | ) | |||
Eliminations | 2,941 | 1,984 | |||||
Adjusted OIBDA - Consolidated | $ | 4,251 | $ | (6,084 | ) |
1 Year AltaGas (PK) Chart |
1 Month AltaGas (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions